Code status transitions in patients with high-risk acute myeloid leukemia.

Abrams, Hannah R; Nipp, Ryan D; Traeger, Lara; Lavoie, Mitchell W; Reynolds, Matthew J; Ufere, Nneka N; Wang, Annie C; Boateng, Kofi; LeBlanc, Thomas W; El-Jawahri, Areej

Abrams, Hannah R; Nipp, Ryan D; Traeger, Lara; Lavoie, Mitchell W; Reynolds, Matthew J; Ufere, Nneka N; Wang, Annie C; Boateng, Kofi; LeBlanc, Thomas W; El-Jawahri, Areej.

Afiliación

Abrams HR; Department of Medicine, and.
Nipp RD; Massachusetts General Cancer Center, Massachusetts General Hospital, Boston MA.
Traeger L; Department of Medicine, Harvard Medical School, Boston, MA; and.
Lavoie MW; Massachusetts General Cancer Center, Massachusetts General Hospital, Boston MA.
Reynolds MJ; Department of Medicine, Harvard Medical School, Boston, MA; and.
Ufere NN; Massachusetts General Cancer Center, Massachusetts General Hospital, Boston MA.
Wang AC; Massachusetts General Cancer Center, Massachusetts General Hospital, Boston MA.
Boateng K; Department of Medicine, and.
LeBlanc TW; Department of Medicine, Harvard Medical School, Boston, MA; and.
El-Jawahri A; Massachusetts General Cancer Center, Massachusetts General Hospital, Boston MA.

Blood Adv ; 6(14): 4208-4215, 2022 07 26.

Article en En | MEDLINE | ID: mdl-35537113

Asunto(s)

Leucemia Mieloide Aguda; Cuidado Terminal; Hospitalización; Humanos; Leucemia Mieloide Aguda/diagnóstico; Leucemia Mieloide Aguda/terapia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_leukemia Asunto principal: Cuidado Terminal / Leucemia Mieloide Aguda Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Blood Adv Año: 2022 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google